AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02627690 — intervention group
Intervention type: OTHER
Intervention: non islet transplanted
Description: no islet transplantation (for a non nephrologic reason)
Study NCT04333316 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: large head
Description: implantation of large head total hip
Study NCT04333316 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: dual mobility cup
Description: implantation of dual mobility total hip
Study NCT02271633 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Beetroot juice
Study NCT00778206 — intervention group
Intervention type: DRUG
Intervention: Kuvan
Description: -Recommended post-partum Assessments include: collection of baby's plasma at Birth, 1 Month and 6 months, and collection of mother's plasma and expressed breast milk sample at 1 Month.
Study NCT04903938 — intervention group
Intervention type: BEHAVIORAL
Intervention: Primary And Secondary Abilities Among The Individuals With Antisocial Personality Disorder Within The Scope Of Positive Psychotherapy: Their Relationship With Criminal Behaviors, Aggression And Anger
Description: Participants will be given scales with validity and reliability studies in Turkish.
Study NCT01132027 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tacrolimus Capsules
Description: Tacrolimus Capsules, 5 mg of Dr. Reddy's Laboratories Limited
Study NCT01132027 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tacrolimus Capsules
Description: Tacrolimus Capsules, 5 mg of Dr. Reddy's Laboratories Limited
Study NCT03801863 — intervention group
Intervention type: PROCEDURE
Intervention: Ultrasound-guided Erector Spinae Plane Block with Ropivacaine 0.375%
Description: Ultrasound-guided Erector Spinae Plane Block will be done at L4 interspace. Ropivacaine 0.375% will be used.
Study NCT03801863 — intervention group
Intervention type: DRUG
Intervention: Ropivacaine
Description: Using 0.375% Ropivacaine in the nerve block
Study NCT00960648 — intervention group
Intervention type: DEVICE
Intervention: Xience/Promus
Description: Active prospective registration of patients receiving everolimus-eluting stent
Study NCT00960648 — intervention group
Intervention type: DEVICE
Intervention: Cypher
Description: Retrospective historical controls that received sirolimus-eluting stent
Study NCT01315626 — intervention group
Intervention type: OTHER
Intervention: Primary Care Educational event
Description: The purpose of this study is to assess the accuracy of primary care physicians in diagnosing BE and evaluate the impact of an educational intervention targeting those primary care physicians and providing instruction in the recognition and treatment of BE. The hope is that a better understanding of the disease will result in more accurate diagnoses and ultimately in more appropriate care for these patients. In addition to better care for patients, earlier recognition of bronchiectasis may result in a decrease in health care costs.
Study NCT00564473 — intervention group
Intervention type: BEHAVIORAL
Intervention: questionnaire
Description: * questionnaire of demographic and medical data, use of and attituded toward herbal medicine.~* Beck Depression Inventory-Second Edition (BDI-II)- Hebrew Translation
Study NCT01969331 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Normia
Description: One capsule twice a day/14 days
Study NCT01969331 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: maltodextrin, microcrystalline cellulose; hypromellose, silicium dioxide (E551), magnesium stearate, colouring agent: titanium dioxide ( E171)
Study NCT03446846 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MIN-117 5.0 mg
Description: 5.0 mg MIN-117 administered as two MIN-117 2.5 mg capsules as a single dose once daily
Study NCT03446846 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MIN-117 2.5 mg
Description: 2.5 mg MIN-117 administered as one MIN-117 2.5 mg capsule and one Placebo capsule as a single dose once daily
Study NCT03446846 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo administered as two Placebo capsules as a single dose once daily
Study NCT03379038 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Progressive Physical Therapy
Description: Stretching of the tight muscle, positioning, abdominal co activation; rolling etc to decrease muscle tone and functional independence.
Study NCT03379038 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Maintenance Physical Therapy
Description: Same Physical therapy protocol but aim was to maintain current level of spasticity and functioning
Study NCT02059681 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Autologous bone marrow derived-CD133+ cells
Description: Cell therapy
Study NCT02719093 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: recombinant FSH
Description: Subcutaneous injection
Study NCT00501969 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rotigotine
Description: Rotigotine trans-dermal patches once daily:~20 cm2 (4 mg/24 hours); 30 cm2 (6 mg/24 hours); 40 cm2 (8 mg/24 hours) 50 cm2 (10 mg/24 hours) 60 cm2 (12 mg/24 hours) 70 cm2 (14 mg/24 hours) 80 cm2 (16 mg/24 hours)
Study NCT02191033 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Smoking counseling
Study NCT02191033 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Smoking counseling
Study NCT02191033 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Text messaging
Study NCT01927484 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 25 mg/week oral methotrexate tablets
Description: active oral methotrexate drug
Study NCT01927484 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: 25mg/week oral placebo tablets
Description: placebo comparator oral drug
Study NCT03169855 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Slit lamp (LOCS III Score)
Description: Diagnostic procedure only
Study NCT04285645 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Warmup
Description: The intervention through exercises will consist in the application of the protocol described by Waldén et al. The objective of the application of this exercise protocol is to produce an improvement in the stability of the knee and the strength of the quadriceps. Before carrying out the exercises, a continuous race will be carried out for 5 minutes, once this first step is finished we will proceed to the realization of the exercises that will be, squats with both legs placing the hands on the hips, feet placed at the width of the shoulders, lowering with a straight back and without raising the heels of the floor, 3 series of 15 repetitions, squats on one leg with the hands on the hips and leg not supported extended forward, 3 sets of 10 repetitions with each leg and jump forward with one leg with the hands on the hips and jump back to return to the starting position, 3 sets of 10 repetitions with each leg
Study NCT02191033 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nicotine patch
Study NCT02191033 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nicotine patch
Study NCT01574976 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: probabilistic choice
Description: subjects should choose between low-certain outcome and high-uncertain outcome
Study NCT01574976 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: probabilistic choice
Description: subjects should choose between low-certain outcome and high-uncertain outcome
Study NCT04085562 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bisoprolol Fumarate 5-10 mg
Description: Bisoprolol as antihypertensive drug in patients on hemodialysis
Study NCT04085562 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amlodipine 5-10 mg
Description: Amlodipine as antihypertensive drug in patients on hemodialysis
Study NCT02737241 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Low power Holmium laser enucleation of the prostate
Description: HoLEP entails dissection of the whole median and lateral prostatic lobes off the surgical capsule via a retrograde approach starting at the apex. The enucleated lobes were pushed to the bladder followed by hemostasis of the prostate bed then intravesical morcellation of the enucleated adenoma. The procedure entails power setting of 50W holmium laser energy.
Study NCT02737241 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: High power Holmium laser enucleation of the prostate
Description: HoLEP entails dissection of the whole median and lateral prostatic lobes off the surgical capsule via a retrograde approach starting at the apex. The enucleated lobes were pushed to the bladder followed by hemostasis of the prostate bed then intravesical morcellation of the enucleated adenoma. The procedure entails power setting of 100W holmium laser energy.
Study NCT03707210 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: VR training program
Description: Use VR software to make a training education program.
Study NCT03131791 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Shock Wave
Description: 42 chronic stroke patients with upper limb spasticity were randomly assigned to receive either 1 session of ESWT per week for 3 consecutive weeks or BoNT-A injection. The biceps, flexor carpi radialis, and flexor carpi ulnaris muscles were treated. Assessments were performed at baseline and at 1, 4, and 8 weeks after the intervention. The primary outcome measure was the change in the Modified Ashworth Scale (MAS) score for the elbow from the baseline to after 4 weeks of treatment.
Study NCT03131791 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Botulinum toxin A
Description: 42 chronic stroke patients with upper limb spasticity were randomly assigned to receive either 1 session of ESWT per week for 3 consecutive weeks or BoNT-A injection. The biceps, flexor carpi radialis, and flexor carpi ulnaris muscles were treated. Assessments were performed at baseline and at 1, 4, and 8 weeks after the intervention. The primary outcome measure was the change in the Modified Ashworth Scale (MAS) score for the elbow from the baseline to after 4 weeks of treatment.
Study NCT02057549 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Haloperidol
Description: Intravenous dose of haloperidol 5 mg.
Study NCT02057549 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Therapy
Description: Conventional Therapy includes hydration via IV fluids, pain control with analgesics (usually opiates) frequently requiring multiple doses, also antiemetics (often requires multiple doses and different agents in attempts to control nausea and vomiting within this population), in addition to electrolytes abnormalities corrections as needed.
Study NCT01738347 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Arm 1 - GEH120714 (18F) Injection
Description: Intervention is to administer GEH120714 (18F) Injection (100-270 Megabecquerel (MBq), single intravenous administration).
Study NCT03165812 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: SADJB-SG group
Description: Patients will undergo bariatric surgery. A clear liquid high protein diet will be started in the first two postoperative days. If no complications were detected by physical examination, patients will be stimulated to walk and will be dismissed from the hospital on postoperative day 3. Patients will be subjected to a strict adherence to diet and close monitoring of their blood glucose and HbA1c levels during the study period. Standard follow-up includes a visit to the outpatient clinic at 1, 2, 3, 4 weeks after surgery, then 3, 6, 9, 12, 18, 24 months and after that, a life-long annual visit. Glycaemic control at home will be maintained as in the preoperative period and patients will need to inform the results of their blood glucose levels to the doctor during each follow-up visits.
Study NCT03165812 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: IMT group
Description: Patients will be subjected to strict adherence to their diet, optimisation of their diabetic medications and close monitoring of their blood glucose and HbA1c levels at 0, 6, 12, 24 months. The endocrinologist will be monitoring the patients in this group. Detailed individualized lifestyle and dietary counseling will be given by a dietitian emphasizing on nutrition knowledge, the timing of meal with medication, portion control, and increasing daily physical activity level.
Study NCT01277783 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Endocardial Left Ventricular pacing
Description: Subjects receive an endocardial LV lead placement via superior approach using Medtronic Model 3830 lead and Medtronic Model 6227ATS deflectable delivery catheter and Medtronic Model 6248HS, 6248JL, or 6248JS delivery catheter, using trans esophageal echo (TEE) or intra-cardiac echo (ICE) to guide the procedure.
Study NCT02174627 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Roxadustat
Description: The initial study drug dose is 70 mg three times a week (TIW). The dose is subsequently adjusted to achieve and maintain Hb 11±1 g/dL.
Study NCT02174627 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The initial study drug dose is 70 mg three times a week (TIW). The dose is subsequently adjusted to achieve and maintain Hb 11±1 g/dL.
Study NCT00107627 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Caprosyn subcuticular sutures.
Description: Caprosyn subcuticular sutures.
Study NCT00107627 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Monocryl subcuticular sutures.
Description: Monocryl subcuticular sutures.
Study NCT00107627 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Skin staples;
Description: Skin staples;
Study NCT02271633 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Spinach
Study NCT02271633 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Rocket salad
Study NCT01354496 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY2409021 Reference Form
Description: Administered orally
Study NCT01354496 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY2409021 Test-Med Formulation (medium particle size)
Description: Administered orally
Study NCT01354496 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY2409021 Test-High Formulation (high particle size)
Description: Administered orally
Study NCT01354496 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY2409021 Test-Low Formulation (low particle size)
Description: Administered orally
Study NCT03978975 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Food intake
Description: For all those session, subjects will take a standardized breakfast (570kcal) three hours before experimental session.~Control session (CON): subject will stand sited without any activity during 40 min.~Subjects will be submitted to three aquatic cycling exercise session:~* session 27°C :aquatic cycling at 27°C without water jet during 40 min~* session 27°C+ water jets : aquatic cycling at 27 °C with water jets during 40 min~* session 18°C : aquatic cycling at 187°C without water jet during 40 min Every exercise session will be set at 70% of theorical maximal heart rate During each session, oxygen consumption and carbon dioxide production will be analysed with gas analysis system. Appetite and hunger sensation will be measured with a specific scale at different time point of each day of experimental session. Thirty minutes after the end of each experimental session subjects will have a buffet meal for lunch time.
Study NCT03978975 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Food intake
Description: For all those session, subjects will take a standardized breakfast (570kcal) three hours before experimental session.~Control session (CON): subject will stand sited without any activity during 40 min.~Subjects will be submitted to three aquatic cycling exercise session:~* session 27°C :aquatic cycling at 27°C without water jet during 40 min~* session 27°C+ water jets : aquatic cycling at 27 °C with water jets during 40 min~* session 18°C : aquatic cycling at 187°C without water jet during 40 min Every exercise session will be set at 70% of theorical maximal heart rate During each session, oxygen consumption and carbon dioxide production will be analysed with gas analysis system. Appetite and hunger sensation will be measured with a specific scale at different time point of each day of experimental session. Thirty minutes after the end of each experimental session subjects will have a buffet meal for lunch time.
Study NCT01159964 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Immunotherapeutic GSK2302032A, different formulations
Description: Intramuscular administration
Study NCT02869373 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: spinal stabilizaton exercise
Description: In Exercise group, spinal stabilization exercise program was carried out 3 days a week for 8 weeks.
Study NCT01448070 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: human insulin
Description: Single dose of 0.2 IU/kg, administered subcutaneously (under the skin)
Study NCT01448070 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: human insulin
Description: Single dose of 0.2 IU/kg, administered subcutaneously (under the skin)
Study NCT04025697 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Complete Denture
Description: A conventional CD will be constructed
Study NCT04025697 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Rapid prototyped denture
Description: A 3d printed complete denture will be constructed
Study NCT04060901 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CCSH Intervention for Teams
Description: CCSH Interventions for Teams will be a six session intervention. The groups meet once per week for 60 minutes for 4 weeks, coupled with 2 booster sessions over the following 2 months. Participants will receive the CCSH interventional approach, adapted for a group setting, which follows four stages: 1) Preparing the care responder; 2) Attuning to the Relationship; 3) Accessing Compassion, and 4) Entrusting the Careseeker.~The CCSH approach will be used to assess group dynamics, individual member sources of distress, as well as existing resources for resilience and compassion. Through the intervention, resources will then be identified and accessed in order to respond to team (and individual) sources of distress with greater resilience and increased compassion toward self and others. CCSH clinicians will utilize group process skills to encourage team communication about work-related challenges, enhance team cohesion, and enable interpersonal support among members of the team.
Study NCT01081431 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide
Description: 10 mg d1-d21 of a 28-day cycle
Study NCT00942110 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CPAP treatment
Description: maintains upper airway patency and minimizes the obstructive events
Study NCT03290131 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Arbaclofen
Description: Arbaclofen Extended Release Tablet
Study NCT03290131 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo comparator
Study NCT03327935 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Nutrition
Description: 150 Faroese surgical patients randomized to one of the following three arms 1) oral nutritional supplements and advice, 2) oral nutritional supplements and training exercise and 3) Standard hospital procedure. Primary outcome is loss of lean body mass
Study NCT05290636 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Teaching intervention program
Description: Using an action research approach, The investigators designed a pair of geriatric nursing and practicum courses and recruited a class of in-service nursing students through convenience sampling in a college setting. The intervention was an 18-week course in geriatric nursing that meets once a week in the classroom and internship practice in settings used for training nursing students. The investigators collected data using quantitative indicators (attitude measurements) and qualitative textual analysis. The quantitative data were analyzed by paired t-testing using SPSS 21.0 software.
Study NCT01970423 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: CRT
Description: The new device is the first CRT-P that relies on a physiological parameter, respiration, to allow the pacemaker to follow the patient's breath and help create an appropriate pacing rate.
Study NCT01970423 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: conventional right ventricular stimulation
Study NCT04045041 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Acceptance and commitment therapy
Description: An acceptance based intervention with focus on exposure.
Study NCT04331431 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Spinal cord tumor resection
Description: Excision of intradural tumors
Study NCT01040806 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual care
Description: Patients will receive their usual medical care
Study NCT01040806 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Health coaching
Description: Peer health coaches will counsel patients with diabetes
Study NCT03417648 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Plant-based diet
Description: Weekly instructions will be given to the participants in the intervention group about following vegan diet.
Study NCT03417648 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Supplement
Description: unrestricted diet with clinically insignificant amount of omega- 3 oils and vitamin E
Study NCT00646217 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self Care Talk
Description: 6 weekly telephone sessions